Skip to content

Pharmacokinetics of Omeprazole and Sodium Bicarbonate Suspension in Healthy Chinese Volunteers

Pharmacokinetics of Omeprazole and Sodium Bicarbonate Suspension in Healthy Chinese Volunteers

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15006585
Enrollment
Unknown
Registered
2015-05-20
Start date
2015-06-23
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

duodenal ulcer

Interventions

Group A:Take test drug first, after washout period, then take control drug, including single dose (fasting and non-fasting) and multiple dose oral administration.
Group B:Take control drug first, after washout period, then take test drug, including single dose (fasting and non-fasting) and multiple dose oral administration.

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Healthy subject; 2. 18~45 years old; 3. BMI in range of 19~24kg/m2 [BMI=weight (kg)/height 2(m2)], Great disparity is not allowed in the weight of subjects in the same batch; Male subject weight(min) >60kg, weight(max)45kg, weight(max)<55kg; 4. Blood and urine routine, liver and kidney function, blood lipid, electrolyte, blood sugar and electrocardiogram examination is normal, urine pregnancy test negative in female subjects; 5. Subject should have a strong understand of the object and require of trial, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Allergic history for ingredients of investigator product, Allergic disease , Allergic constitution and Limiting sodium diet; 2. Participate other clinical trial in the last 3 months; 3. Used any medicine in the last 2 weeks; 4. Blood donation and Test blood donation in the last 3 month; 5. any clinical significance dieases; 6. Any history of severe disease or medical history of digestive system,cardiovascular system, Liver, kidney; 7. HIV, HCV, TP-Anti positive; 8. there is the evidence of drug abuse; 9. history of tobacco, alcohol or drug abuse history; 10. Gestation period and lactation period women, menstrual period conflict with trial; 11. Use of contraceptive drugs; 12. Patients with active infections; 13. Subject can't complete the trial because of other reasons or unsuitable to participate in the trial considered by the researchers.

Design outcomes

Primary

MeasureTime frame
AUC0-t;Cmax;Tmax;t1/2z;CLz;Vz;AUCss;Css_min;

Countries

China

Contacts

Public ContactYongping Qin; Ping Feng
617130961@qq.com+86 028-85422031; 028-85423583

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026